356 related articles for article (PubMed ID: 35037830)
21. Design, synthesis, in silico and biological evaluation of new indole based oxadiazole derivatives targeting estrogen receptor alpha.
Kaur K; Verma H; Gangwar P; Jangid K; Dhiman M; Kumar V; Jaitak V
Bioorg Chem; 2024 Jun; 147():107341. PubMed ID: 38593531
[TBL] [Abstract][Full Text] [Related]
22. Hybrids of thiazolidinone with 1,2,3-triazole derivatives: design, synthesis, biological evaluation,
Bimoussa A; Fawzi M; Oubella A; Ejaz SA; Sajjad Bilal M; Labd Taha M; Auhmani A; Morjani H; Robert A; Riahi A; Ait Itto MY
J Biomol Struct Dyn; 2023; 41(21):11987-11999. PubMed ID: 36617941
[TBL] [Abstract][Full Text] [Related]
23. Design, synthesis, molecular docking and cytotoxic evaluation of novel 2-furybenzimidazoles as VEGFR-2 inhibitors.
Abdullaziz MA; Abdel-Mohsen HT; El Kerdawy AM; Ragab FAF; Ali MM; Abu-Bakr SM; Girgis AS; El Diwani HI
Eur J Med Chem; 2017 Aug; 136():315-329. PubMed ID: 28505536
[TBL] [Abstract][Full Text] [Related]
24. New benzothienopyrimidine derivatives as dual EGFR/ARO inhibitors: Design, synthesis, and their cytotoxic effect on MCF-7 breast cancer cell line.
Sobh EA; Khalil NA; Faggal SI; Hassan MSA
Drug Dev Res; 2022 Aug; 83(5):1075-1096. PubMed ID: 35286757
[TBL] [Abstract][Full Text] [Related]
25. 2-Anilinopyrimidine derivatives: Design, synthesis, in vitro anti-proliferative activity, EGFR and ARO inhibitory activity, cell cycle analysis and molecular docking study.
AboulWafa OM; Daabees HMG; Badawi WA
Bioorg Chem; 2020 Jun; 99():103798. PubMed ID: 32247112
[TBL] [Abstract][Full Text] [Related]
26. Molecular docking, QSAR, pharmacophore modeling, and dynamics studies of some chromone derivatives for the discovery of anti-breast cancer agents against hormone-dependent breast cancer.
Arvindekar SA; Mohole S; Patil A; Mane P; Arvindekar A; Mali SN; Thorat B; Rawat R; Sharma S
J Biomol Struct Dyn; 2023; 41(24):14757-14770. PubMed ID: 36995997
[TBL] [Abstract][Full Text] [Related]
27. Design, Synthesis, and Molecular Modeling Studies of a Novel Benzimidazole as an Aromatase Inhibitor.
Çevik UA; Celik I; Mella J; Mellado M; Özkay Y; Kaplancıklı ZA
ACS Omega; 2022 May; 7(18):16152-16163. PubMed ID: 35571854
[TBL] [Abstract][Full Text] [Related]
28. Synthesis of New Pyrimidine-Triazole Derivatives and Investigation of Their Anticancer Activities.
Osmaniye D; Hıdır A; Sağlık BN; Levent S; Özkay Y; Kaplancıklı ZA
Chem Biodivers; 2022 Aug; 19(8):e202200216. PubMed ID: 35699405
[TBL] [Abstract][Full Text] [Related]
29. Design, Synthesis, biological Evaluation, and molecular docking studies of novel Pyrazolo[3,4-d]Pyrimidine derivative scaffolds as potent EGFR inhibitors and cell apoptosis inducers.
Sherbiny FF; Bayoumi AH; El-Morsy AM; Sobhy M; Hagras M
Bioorg Chem; 2021 Nov; 116():105325. PubMed ID: 34507234
[TBL] [Abstract][Full Text] [Related]
30. Identification of new benzimidazole-triazole hybrids as anticancer agents: multi-target recognition,
Othman DIA; Hamdi A; Tawfik SS; Elgazar AA; Mostafa AS
J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2166037. PubMed ID: 36651111
[TBL] [Abstract][Full Text] [Related]
31. New azolyl-derivatives as multitargeting agents against breast cancer and fungal infections: synthesis, biological evaluation and docking study.
Maccallini C; Gallorini M; Sisto F; Akdemir A; Ammazzalorso A; De Filippis B; Fantacuzzi M; Giampietro L; Carradori S; Cataldi A; Amoroso R
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1632-1645. PubMed ID: 34289751
[TBL] [Abstract][Full Text] [Related]
32. New 1,2,3-Triazole/1,2,4-triazole Hybrids as Aromatase Inhibitors: Design, Synthesis, and Apoptotic Antiproliferative Activity.
Maghraby MT; Mazyad Almutairi T; Bräse S; Salem OIA; Youssif BGM; Sheha MM
Molecules; 2023 Oct; 28(20):. PubMed ID: 37894571
[TBL] [Abstract][Full Text] [Related]
33. Novel 7-Chloro-4-aminoquinoline-benzimidazole Hybrids as Inhibitors of Cancer Cells Growth: Synthesis, Antiproliferative Activity, in Silico ADME Predictions, and Docking.
Krstulović L; Leventić M; Rastija V; Starčević K; Jirouš M; Janić I; Karnaš M; Lasić K; Bajić M; Glavaš-Obrovac L
Molecules; 2023 Jan; 28(2):. PubMed ID: 36677600
[TBL] [Abstract][Full Text] [Related]
34. Synthesis, antiproliferative evaluation and in silico studies of a novel steroidal spiro morpholinone.
Cobos-Ontiveros LA; Romero-Hernández LL; Mastranzo-Sánchez EB; Colín-Lozano B; Puerta A; Padrón JM; Merino-Montiel P; Vega Baez JL; Montiel-Smith S
Steroids; 2023 Apr; 192():109173. PubMed ID: 36621620
[TBL] [Abstract][Full Text] [Related]
35. Synthesis, molecular modeling, in vivo study and anticancer activity against prostate cancer of (+) (S)-naproxen derivatives.
Birgül K; Yıldırım Y; Karasulu HY; Karasulu E; Uba AI; Yelekçi K; Bekçi H; Cumaoğlu A; Kabasakal L; Yılmaz Ö; Küçükgüzel ŞG
Eur J Med Chem; 2020 Dec; 208():112841. PubMed ID: 32998089
[TBL] [Abstract][Full Text] [Related]
36. Novel oxadiazole-thiadiazole derivatives: synthesis, biological evaluation, and
Evren AE; Nuha D; Dawbaa S; Karaduman AB; Sağlik BN; Yurttaş L
J Biomol Struct Dyn; 2023 Aug; ():1-13. PubMed ID: 37587853
[TBL] [Abstract][Full Text] [Related]
37. New benzimidazole based hybrids: Synthesis, molecular modeling study and anticancer evaluation as TopoII inhibitors.
Nawareg NA; Mostafa AS; El-Messery SM; Nasr MNA
Bioorg Chem; 2022 Oct; 127():106038. PubMed ID: 35870412
[TBL] [Abstract][Full Text] [Related]
38. Design, synthesis, in vitro and in silico evaluation of a new series of oxadiazole-based anticancer agents as potential Akt and FAK inhibitors.
Altıntop MD; Sever B; Akalın Çiftçi G; Turan-Zitouni G; Kaplancıklı ZA; Özdemir A
Eur J Med Chem; 2018 Jul; 155():905-924. PubMed ID: 29966916
[TBL] [Abstract][Full Text] [Related]
39. Cell Cycle Arrest and Apoptosis-Inducing Ability of Benzimidazole Derivatives: Design, Synthesis, Docking, and Biological Evaluation.
Nazreen S; Almalki ASA; Elbehairi SEI; Shati AA; Alfaifi MY; Elhenawy AA; Alsenani NI; Alfarsi A; Alhadhrami A; Alqurashi EA; Alam MM
Molecules; 2022 Oct; 27(20):. PubMed ID: 36296495
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and Preclinical Evaluation of Indole Triazole Conjugates as Microtubule Targeting Agents that are Effective against MCF-7 Breast Cancer Cell Lines.
Yele V; Pindiprolu SKSS; Sana S; Ramamurty DSVNM; Madasi JRK; Vadlamani S
Anticancer Agents Med Chem; 2021; 21(8):1047-1055. PubMed ID: 32981511
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]